609799-33-9Relevant academic research and scientific papers
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
-
Page/Page column 49-50, (2008/06/13)
Alkyne compounds having MCH-receptor antagonistic activity, which are useful for preparing pharmaceutical compositions for the treatment of metabolic disorders and/or eating disorders, particularly obesity and diabetes.
NOVEL ALKYNE COMPOUNDS WITH AN MCH-ANTAGONISTIC ACTION AND MEDICAMENTS COMPRISING SAID COMPOUNDS
-
Page/Page column 111, (2008/06/13)
The invention relates to individual alkyne compounds with an antagonistic action against the MCH-receptor. Said compounds are suitable for producing medicaments for the treatment of metabolic disorders and/or eating disorders, in particular adiposity and diabetes.
Synthesis and application to asymmetric allylic amination of substituted monodonor diazaphospholidine ligands
Edwards, Christopher W.,Shipton, Mark R.,Alcock, Nathaniel W.,Clase, Howard,Wills, Martin
, p. 6473 - 6480 (2007/10/03)
The synthesis of a series of substituted monodonor diazaphospholidine ligands is described. A regioselective lithiation process is a key step in one of these syntheses. The compounds are designed to be incorporated into soluble polymer and other solid pha
